Loading...
Loading...
Think you know the markets? See if you can guess this stock by the chart and clue below.
- This pharmaceuticals company, which focuses on a specific disease, announced a secondary offering of 3.75 million shares Thursday morning, despite reports of weak investor demand
- A former executive at this company was charged with insider trading ahead of a drug data release in September
- Sympathy plays include Cascadian Therapeutics Inc (USA) CASC Array Biopharma Inc ARRY MacroGenics Inc MGNX
Answer: Puma Biotechnology Inc PBYI
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: General
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in